These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 3513894)

  • 1. Neuroanatomical aspects of neurotransmitters affected in Alzheimer's disease.
    Emson PC; Lindvall O
    Br Med Bull; 1986 Jan; 42(1):57-62. PubMed ID: 3513894
    [No Abstract]   [Full Text] [Related]  

  • 2. Systematic regional variations in the loss of cortical cholinergic fibers in Alzheimer's disease.
    Geula C; Mesulam MM
    Cereb Cortex; 1996; 6(2):165-77. PubMed ID: 8670647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Approaches to cholinergic therapy in Alzheimer's disease.
    Iversen LL
    Prog Brain Res; 1993; 98():423-6. PubMed ID: 8248531
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental studies on the induction and prevention of retrograde degeneration of basal forebrain cholinergic neurons.
    Sofroniew MV; Pearson RC; Isacson O; Björklund A
    Prog Brain Res; 1986; 70():363-89. PubMed ID: 3554356
    [No Abstract]   [Full Text] [Related]  

  • 5. Neurotransmitters and second messengers in aging and Alzheimer's disease.
    Francis PT; Webster MT; Chessell IP; Holmes C; Stratmann GC; Procter AW; Cross AJ; Green AR; Bowen DM
    Ann N Y Acad Sci; 1993 Sep; 695():19-26. PubMed ID: 7902054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Significance of neurotransmitter abnormalities in Alzheimer's disease.
    Katzman R; Brown T; Fuld P; Thal L; Davies P; Terry R
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():279-86. PubMed ID: 2873637
    [No Abstract]   [Full Text] [Related]  

  • 7. Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease.
    Aucoin JS; Jiang P; Aznavour N; Tong XK; Buttini M; Descarries L; Hamel E
    Neuroscience; 2005; 132(1):73-86. PubMed ID: 15780468
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic neuropathology in a mouse model of Alzheimer's disease.
    German DC; Yazdani U; Speciale SG; Pasbakhsh P; Games D; Liang CL
    J Comp Neurol; 2003 Aug; 462(4):371-81. PubMed ID: 12811807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cholinergic system in Alzheimer's disease and dementia with Lewy bodies: from animal models to neuropathological data.
    Liberini P
    Funct Neurol; 1997; 12(3-4):153-7. PubMed ID: 9218969
    [No Abstract]   [Full Text] [Related]  

  • 10. Modeling cholinergic abnormalities in Down syndrome and Alzheimer's disease.
    Holtzman DM; Li YW; Gage FH; DeArmond SJ; Epstein CJ; McKinley MP; Mobley WC
    Prog Clin Biol Res; 1991; 373():189-202. PubMed ID: 1838184
    [No Abstract]   [Full Text] [Related]  

  • 11. Overview of morphological changes in Parkinson's disease.
    Jellinger K
    Adv Neurol; 1987; 45():1-18. PubMed ID: 3825687
    [No Abstract]   [Full Text] [Related]  

  • 12. The cholinergic system and the excitatory amino acids in Alzheimer's disease.
    Bowen D
    Acta Neurol Scand Suppl; 1990; 129():15-6. PubMed ID: 2220318
    [No Abstract]   [Full Text] [Related]  

  • 13. Alzheimer's disease: a multisystem disorder.
    Price DL; Struble RG; Whitehouse PJ; Kitt CA; Cork LC; Walker LC; Casanova MF
    Res Publ Assoc Res Nerv Ment Dis; 1986; 64():209-14. PubMed ID: 3523660
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroanatomical evidence for a cholinergic deficit in Alzheimer's disease.
    Whitehouse PJ; Struble RG; Hedreen JC; Clark AW; White CL; Parhad IM; Price DL
    Psychopharmacol Bull; 1983; 19(3):437-40. PubMed ID: 6635120
    [No Abstract]   [Full Text] [Related]  

  • 15. Do lesions involving the cortical cholinergic pathways help or hinder efficacy of donepezil in patients with Alzheimer's disease?
    Fukui T; Hieda S; Bocti C
    Dement Geriatr Cogn Disord; 2006; 22(5-6):421-31. PubMed ID: 16974095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuronal pathology in relation to molecular biology and treatment of Alzheimer's disease.
    Francis PT; Bowen DM
    Mol Cell Biol Hum Dis Ser; 1994; 4():25-54. PubMed ID: 9439743
    [No Abstract]   [Full Text] [Related]  

  • 17. [Pathogenetic factors of Alzheimer disease].
    Bauer J; Hüll M; Berger M
    Z Gerontol Geriatr; 1995; 28(3):155. PubMed ID: 7664189
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cholinergic innervation of the human cerebral cortex.
    Mesulam MM
    Prog Brain Res; 2004; 145():67-78. PubMed ID: 14650907
    [No Abstract]   [Full Text] [Related]  

  • 19. Pro- and anti-apoptotic evidence for cholinergic denervation and hippocampal sympathetic ingrowth in rat dorsal hippocampus.
    Harrell LE; Parsons DS; Kolasa K
    Exp Neurol; 2005 Jul; 194(1):182-90. PubMed ID: 15899255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathology of psychotic symptoms in Alzheimer's disease.
    Bondareff W
    Int Psychogeriatr; 1996; 8 Suppl 3():233-7; discussion 269-72. PubMed ID: 9154569
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.